Misty Summers, APRN
Adult Health · Fishersville, VANPI 1134634371
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,025 of the $3,459 with a category attached, or 87.5%. 27 manufacturers reported payments, led by AbbVie at 24.1% of the total.
Across 169 payments — averaging $20.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$835
- Sun Pharmaceutical Industries Inc.$501
- Regeneron Healthcare Solutions, Inc.$443
- Johnson & Johnson$280
- Incyte Corporation$181
- Amgen$142
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,02587%
- Education$43413%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 38 | $835 |
| Sun Pharmaceutical Industries Inc. | 25 | $501 |
| Regeneron Healthcare Solutions, Inc. | 23 | $443 |
| Johnson & Johnson | 8 | $280 |
| Incyte Corporation | 8 | $181 |
| Amgen | 7 | $142 |
| E.r. Squibb & Sons, L.L.C. | 7 | $126 |
| Novo Nordisk | 9 | $113 |
| Lilly USA, LLC | 5 | $109 |
| Sanofi | 5 | $99 |
| Pfizer | 5 | $93 |
| UCB, Inc. | 5 | $74 |
| Paratek Pharmaceuticals, Inc. | 3 | $63 |
| Novartis | 3 | $58 |
| Arcutis Biotherapeutics, Inc. | 3 | $54 |
| LEO Pharma Inc. | 2 | $49 |
| Biohaven Pharmaceuticals, Inc. | 1 | $37 |
| ANI Pharmaceuticals, Inc. | 1 | $29 |
| Biofrontera Inc. | 3 | $28 |
| Dermavant Sciences, Inc. | 1 | $25 |
| Fidia Pharma USA Inc. | 1 | $23 |
| Genentech USA, Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| AstraZeneca | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Revance Therapeutics, Inc. | 1 | $14 |
| Galderma Laboratories, L.p. | 1 | $14 |
How this compares
$3,459 in reported general payments places this provider in the 85th percentile of 368 adult health providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 78 | $3,935 |
| Triamcinolone Acetonide | 201 | $2,262 |
| Ketoconazole | 114 | $1,803 |
| Metronidazole | 25 | $1,203 |
| Betamethasone Dipropionate | 28 | $902 |
| Doxycycline Hyclate | 39 | $632 |
| Mupirocin | 34 | $260 |
| Nystatin | 14 | $196 |
| Hydrocortisone | 22 | $164 |
| MethotrexateMethotrexate Sodium | 13 | $2 |
Paid to pharmacies, not to this prescriber.
Other adult health in Fishersville
- Christy AndrewsFishersville$7K
- Christine KesslerFort Belvoir$107K
- Denise BruenCharlottesville$45K
- Theresa Harrington StukusFairfax$40K
- Chelsea KoskovichFredericksburg$34K
- Brittany BrownLynchburg$14K
- Colleen DieringVirginia Beach$13K
- Veronica HughesRichmond$12K
- Nicole SellersNorfolk$12K
- Amy WenzelMechanicsville$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.